Table 1

Baseline Clinical and Echocardiographic Characteristics (N = 7)

Age, yrs76 ± 13
Male4 (57)
NYHA functional class ≥III6 (86)
Coronary artery disease6 (86)
Prior open heart surgery5 (71)
Prior valve surgery4 (57)
 Mitral2 (29)
 Aortic2 (29)
COPD1 (14)
Permanent atrial fibrillation5 (71)
Pulmonary hypertension5 (71)
Creatinine clearance <60 ml/min (eGFR)6 (86)
Hemodialysis1 (14)
Logistic EuroSCORE, %25.7 ± 17.4
6-Min walk test, m297 ± 66
Kansas City Cardiomyopathy Questionnaire59.6 ± 14.1
Daily furosemide dose, mg80 ± 61
Baseline echocardiogram
 LVEF, %56 ± 5
 PAPs, mm Hg69.7 ± 6.0
 MR grade
 Mild3 (43)
 Mild to moderate3 (43)
 Moderate1 (14)
 Severe TR grade7 (100)
 Vena contracta, mm15.5 ± 5.1
 TAPSE, mm16.5 ± 4.2
 TAPSV, cm/s10.6 ± 2.0
 RV diameter, mm47 ± 7
Baseline CT data
 Tricuspid valve major diameter, mm50.3 ± 6.0
 Tricuspid valve minor diameter, mm43.2 ± 2.0

Values are mean ± SD or n (%).

COPD = chronic obstructive pulmonary disease; CT = computed tomography; eGFR = estimated glomerular filtration rate; LVEF = left ventricular ejection fraction; MR = mitral regurgitation; NYHA = New York Heart Association; PAPs = systolic pulmonary artery pressure; RV = right ventricle; TAPSE = tricuspid annular plane systolic excursion; TAPSV = tricuspid annular peak velocity; TR = tricuspid regurgitation.